| Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis C Wei, S El Hindi, J Li, A Fornoni, N Goes, J Sageshima, D Maiguel, ... Nature medicine 17 (8), 952-960, 2011 | 1005 | 2011 |
| Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis A Fornoni, J Sageshima, C Wei, S Merscher-Gomez, R Aguillon-Prada, ... Science translational medicine 3 (85), 85ra46-85ra46, 2011 | 606 | 2011 |
| Abatacept in B7-1–positive proteinuric kidney disease CC Yu, A Fornoni, A Weins, S Hakroush, D Maiguel, J Sageshima, ... New England Journal of Medicine 369 (25), 2416-2423, 2013 | 445 | 2013 |
| Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation S Tamura, T Kato, M Berho, EP Misiakos, C O'Brien, KR Reddy, JR Nery, ... Archives of surgery 136 (1), 25-30, 2001 | 303 | 2001 |
| A randomized trial of three renal transplant induction antibodies: Early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring1 G Ciancio, GW Burke, JJ Gaynor, MR Carreno, RE Cirocco, JM Mathew, ... Transplantation 80 (4), 457-465, 2005 | 253 | 2005 |
| Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous … K Zucker, A Rosen, A Tsaroucha, L De Faria, D Roth, G Ciancio, ... Transplant immunology 5 (3), 225-232, 1997 | 252 | 1997 |
| Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T … F Vendrame, A Pileggi, E Laughlin, G Allende, A Martin-Pagola, ... Diabetes 59 (4), 947-957, 2010 | 236 | 2010 |
| Dissociation of depletional induction and posttransplant lymphoproliferative disease in kidney recipients treated with alemtuzumab AD Kirk, WS Cherikh, M Ring, G Burke, D Kaufman, SJ Knechtle, S Potdar, ... American journal of transplantation 7 (11), 2619-2625, 2007 | 236 | 2007 |
| POSTTRANSPLANT HYPERGLYCEMIA: Increased Incidence in Cyclosporine-Treated Renal Allograft Recipients “ D Roth, M Milgrom, V Esquenazi, L Fuller, G Burke, J Miller Transplantation 47 (2), 278-281, 1989 | 233 | 1989 |
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation M Delville, TK Sigdel, C Wei, J Li, SC Hsieh, A Fornoni, GW Burke, ... Science translational medicine 6 (256), 256ra136-256ra136, 2014 | 229 | 2014 |
| The impact of hepatitis C virus infection on renal allograft recipients D Roth, K Zucker, R Cirocco, A DeMattos, GW Burke, J Nery, V Esquenazi, ... Kidney international 45 (1), 238-244, 1994 | 221 | 1994 |
| Long-term function (6 years) of islet allografts in type 1 diabetes R Alejandro, R Lehmann, C Ricordi, NS Kenyon, MC Angelico, G Burke, ... Diabetes 46 (12), 1983-1989, 1997 | 210 | 1997 |
| A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival … G Ciancio, GW Burke, JJ Gaynor, A Mattiazzi, D Roth, W Kupin, M Nicolas, ... Transplantation 77 (2), 252-258, 2004 | 185 | 2004 |
| Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease TH Yoo, CE Pedigo, J Guzman, M Correa-Medina, C Wei, R Villarreal, ... Journal of the American Society of Nephrology 26 (1), 133-147, 2015 | 176 | 2015 |
| A MULTICENTER ANALYSIS OF THE FIRST EXPERIENCE WITH FK506 FOR INDUCTION AND RESCUE THERAPY AFTER PANCREAS TRANSPLANTATION1 RWG Gruessner, GW Burke, R Stratta, H Sollinger, E Benedetti, C Marsh, ... Transplantation 61 (2), 261-273, 1996 | 175 | 1996 |
| Cyclodextrin protects podocytes in diabetic kidney disease S Merscher-Gomez, J Guzman, CE Pedigo, M Lehto, R Aguillon-Prada, ... Diabetes 62 (11), 3817-3827, 2013 | 167 | 2013 |
| Local TNF causes NFATc1-dependent cholesterol-mediated podocyte injury CE Pedigo, GM Ducasa, F Leclercq, A Sloan, A Mitrofanova, T Hashmi, ... The Journal of clinical investigation 126 (9), 3336-3350, 2016 | 163 | 2016 |
| SIX-YEAR CLINICAL EFFECT OF DONOR BONE MARROW INFUSIONS IN RENAL TRANSPLANT PATIENTS1 G Ciancio, J Miller, RO Garcia-Morales, M Carreno, GW Burke III, D Roth, ... Transplantation 71 (7), 827-835, 2001 | 162 | 2001 |
| De novo membranoproliferative glomerulonephritis in hepatitis C virus–infected renal allograft recipients D Roth, R Cirocco, K Zucker, P Ruiz, A Viciana, G Burke, M Carreno, ... Transplantation 59 (12), 1676-1682, 1995 | 160 | 1995 |
| Effect of kidney transplantation on outcomes among patients with hepatitis C D Roth, JJ Gaynor, KR Reddy, G Ciancio, J Sageshima, W Kupin, ... Journal of the American Society of Nephrology 22 (6), 1152-1160, 2011 | 155 | 2011 |
